Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8615547 | Clinical Lymphoma Myeloma and Leukemia | 2018 | 8 Pages |
Abstract
Survival of acute leukemia patients who experience relapse after allogeneic HSCT is poor, especially in elderly patients and those who do not experience remission after relapse treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Amro M.S. El-Ghammaz, Mostafa K. El-Razzaz,